North American Biologicals Inc. (NABI) and AbbottLaboratories announced the complete transfer from Abbott toNABI of all rights and assets associated with HIV immuneglobulin (HIVIG), an experimental immune globulin that mayprevent the transmission of AIDS from HIV-positive mothers tounborn infants. HIVIG is prepared from the plasma of HIVantibody- positive healthy donors who have a strong immuneresponse to the virus.

This completes the October transaction in which NABI(NASDAQ:NBIO) also got Abbott's hepatitis B immune globulinproduct and Abbott picked up 16 percent of the Miamicompany's shares and royalties from sales of the transferredproducts. -- Jennifer Van Brunt

(c) 1997 American Health Consultants. All rights reserved.